These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16415907)

  • 1. Vasorelaxant effects of oleamide in rat small mesenteric artery indicate action at a novel cannabinoid receptor.
    Hoi PM; Hiley CR
    Br J Pharmacol; 2006 Mar; 147(5):560-8. PubMed ID: 16415907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.
    White R; Hiley CR
    Br J Pharmacol; 1997 Dec; 122(8):1573-84. PubMed ID: 9422801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular pharmacology of a novel cannabinoid-like compound, 3-(5-dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1-methyl-ethyl)benzamide (VSN16) in the rat.
    Hoi PM; Visintin C; Okuyama M; Gardiner SM; Kaup SS; Bennett T; Baker D; Selwood DL; Hiley CR
    Br J Pharmacol; 2007 Nov; 152(5):751-64. PubMed ID: 17891160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms involved in oleamide-induced vasorelaxation in rat mesenteric resistance arteries.
    Sudhahar V; Shaw S; Imig JD
    Eur J Pharmacol; 2009 Apr; 607(1-3):143-50. PubMed ID: 19326479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of vasorelaxation induced by oleoylethanolamide in the rat small mesenteric artery.
    AlSuleimani YM; Hiley CR
    Eur J Pharmacol; 2013 Feb; 702(1-3):1-11. PubMed ID: 23340219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bed.
    Harris D; McCulloch AI; Kendall DA; Randall MD
    J Physiol; 2002 Mar; 539(Pt 3):893-902. PubMed ID: 11897858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in the relative contributions of nitric oxide and EDHF to agonist-stimulated endothelium-dependent relaxations in the rat isolated mesenteric arterial bed.
    McCulloch AI; Randall MD
    Br J Pharmacol; 1998 Apr; 123(8):1700-6. PubMed ID: 9605578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
    Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G
    Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries.
    O'Sullivan SE; Kendall DA; Randall MD
    Br J Pharmacol; 2004 Jun; 142(3):435-42. PubMed ID: 15148250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of Delta9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide.
    O'Sullivan SE; Kendall DA; Randall MD
    Br J Pharmacol; 2005 Jun; 145(4):514-26. PubMed ID: 15821751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
    Herradón E; Martín MI; López-Miranda V
    Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery.
    Ho WS; Hiley CR
    J Pharm Pharmacol; 2004 Jul; 56(7):869-75. PubMed ID: 15233865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.
    White R; Ho WS; Bottrill FE; Ford WR; Hiley CR
    Br J Pharmacol; 2001 Oct; 134(4):921-9. PubMed ID: 11606334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery.
    Ho WS; Hiley CR
    Br J Pharmacol; 2003 Apr; 138(7):1320-32. PubMed ID: 12711633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid CB1 receptor and endothelium-dependent hyperpolarization in guinea-pig carotid, rat mesenteric and porcine coronary arteries.
    Chataigneau T; Félétou M; Thollon C; Villeneuve N; Vilaine JP; Duhault J; Vanhoutte PM
    Br J Pharmacol; 1998 Mar; 123(5):968-74. PubMed ID: 9535027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced vasorelaxant effects of the endocannabinoid-like mediator, oleamide, in hypertension.
    Hopps JJ; Dunn WR; Randall MD
    Eur J Pharmacol; 2012 Jun; 684(1-3):102-7. PubMed ID: 22465182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial nitric oxide modulates perivascular sensory neurotransmission in the rat isolated mesenteric arterial bed.
    Ralevic V
    Br J Pharmacol; 2002 Sep; 137(1):19-28. PubMed ID: 12183327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oleamide: a fatty acid amide signaling molecule in the cardiovascular system?
    Hiley CR; Hoi PM
    Cardiovasc Drug Rev; 2007; 25(1):46-60. PubMed ID: 17445087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term inhibition of nitric oxide synthase potentiates effects of anandamide in the rat mesenteric bed.
    Mendizábal VE; Orliac ML; Adler-Graschinsky E
    Eur J Pharmacol; 2001 Sep; 427(3):251-62. PubMed ID: 11567656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and modulation of EDHF-mediated relaxations in the rat isolated superior mesenteric arterial bed.
    McCulloch AI; Bottrill FE; Randall MD; Hiley CR
    Br J Pharmacol; 1997 Apr; 120(8):1431-8. PubMed ID: 9113362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.